Showing results (71-80 of 269) with videos related to
Sort By:
Pageof 27
International Journal of Oncology|March 9, 2005
Altered expression of members of the IGF-axis in clear cell renal cell carcinomaMasayuki Takahashi, Veronica Papavero, Jason Yuhas, et al.Cancer Research|August 9, 2003
Inactivation of BHD in sporadic renal tumorsSok Kean Khoo, Katherine Kahnoski, Jun Sugimura, et al.Oncogene|February 19, 2002
Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndromeWeng Onn Lui, Jindong Chen, Sven Gläsker, et al.Anticancer Research|January 1, 2015
Inhibition of placental growth factor in renal cell carcinomaHideharu Bessho, Bernice Wong, Dan Huang, et al.Annals of the Academy of Medicine, Singapore|April 14, 2012
2011 Young Surgeon's Award Winner: high endothelial venules: a novel prognostic marker in cancer metastasis and the missing link?Ser Yee Lee, Chao Nan Qian, Aik Seng Ooi, et al.Journal of Clinical Pathology|October 31, 2019
MED12, TERT and RARA in fibroepithelial tumours of the breastHuan Ying Chang, Valerie Cui Yun Koh, Nur Diyana Md Nasir, et al.NPJ Genomic Medicine|November 26, 2020
Functional characterisation guides classification of novel BAP1 germline variantsJing Han Hong, Siao Ting Chong, Po-Hsien Lee, et al.Genome Research|April 11, 2018
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumorsArnoud Boot, Mi Ni Huang, Alvin W T Ng, et al.Molecular Cancer Therapeutics|August 20, 2013
Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cellsRan-Yi Liu, Zizheng Dong, Jianguo Liu, et al.Breast Cancer Research : BCR|March 24, 2018
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancerYew Chung Tang, Szu-Chi Ho, Elisabeth Tan, et al.Pageof 27